MedTrace Logo

Quality of Life in Patients With Primary Sclerosing Cholangitis

NCT02712736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2020-01-30

No results posted yet for this study

Summary

The purpose of this study is to assess the healthcare-related quality of life (HRQOL), the impact of risk of liver transplant and risk of malignancy on HRQOL, and the complementary and alternative medicine use in patients with PSC.

Conditions

  • Primary Sclerosing Cholangitis

Interventions

OTHER

quality of life survey

subjects with PSC will be administered a survey to assess their quality of life

Sponsors & Collaborators

Principal Investigators

  • Andrew Muir, MD · Duke University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2018-09-22
Completion
2018-09-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02712736 on ClinicalTrials.gov